NO924800L - Nye pyridylderivater, legemidler inneholdende dem, og fremgangsmaate for deres fremstilling - Google Patents
Nye pyridylderivater, legemidler inneholdende dem, og fremgangsmaate for deres fremstillingInfo
- Publication number
- NO924800L NO924800L NO92924800A NO924800A NO924800L NO 924800 L NO924800 L NO 924800L NO 92924800 A NO92924800 A NO 92924800A NO 924800 A NO924800 A NO 924800A NO 924800 L NO924800 L NO 924800L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- derivatives
- thromboxane
- group
- general formula
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 abstract 3
- 229960002986 dinoprostone Drugs 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 abstract 2
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 abstract 1
- XEYBRNLFEZDVAW-DODZYUBVSA-N 7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)CC(=O)[C@@H]1CC=CCCCC(O)=O XEYBRNLFEZDVAW-DODZYUBVSA-N 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 abstract 1
- 101000988802 Homo sapiens Hematopoietic prostaglandin D synthase Proteins 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000002785 anti-thrombosis Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- BHMBVRSPMRCCGG-OUTUXVNYSA-N prostaglandin D2 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@@H](O)CC1=O BHMBVRSPMRCCGG-OUTUXVNYSA-N 0.000 abstract 1
- BHMBVRSPMRCCGG-UHFFFAOYSA-N prostaglandine D2 Natural products CCCCCC(O)C=CC1C(CC=CCCCC(O)=O)C(O)CC1=O BHMBVRSPMRCCGG-UHFFFAOYSA-N 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Silicon Polymers (AREA)
- Electroluminescent Light Sources (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4141377A DE4141377A1 (de) | 1991-12-14 | 1991-12-14 | Neue pyridylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE4216364A DE4216364A1 (de) | 1991-12-14 | 1992-05-18 | Neue Pyridylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| DE4216829A DE4216829A1 (de) | 1991-12-14 | 1992-05-21 | Neue Pyridylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO924800D0 NO924800D0 (no) | 1992-12-11 |
| NO924800L true NO924800L (no) | 1993-06-15 |
| NO179173B NO179173B (no) | 1996-05-13 |
| NO179173C NO179173C (no) | 1996-08-21 |
Family
ID=27203214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO924800A NO179173C (no) | 1991-12-14 | 1992-12-11 | Nye pyridylderivater, legemidler inneholdende dem |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5482948A (no) |
| EP (1) | EP0547517B1 (no) |
| JP (1) | JP2965425B2 (no) |
| KR (1) | KR100227441B1 (no) |
| AT (1) | ATE122658T1 (no) |
| AU (1) | AU653455B2 (no) |
| CA (1) | CA2085201C (no) |
| DE (3) | DE4216364A1 (no) |
| DK (1) | DK0547517T3 (no) |
| ES (1) | ES2074323T3 (no) |
| FI (1) | FI100882B (no) |
| HU (3) | HUT68032A (no) |
| IL (1) | IL104066A (no) |
| NO (1) | NO179173C (no) |
| NZ (1) | NZ245445A (no) |
| PL (3) | PL171463B1 (no) |
| RU (1) | RU2119915C1 (no) |
| TW (1) | TW293816B (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9602489A3 (en) * | 1995-01-11 | 1998-01-28 | Samjin Pharm Co Ltd | Piperazine derivatives, process for producing them and pharmaceutical compositions containing them |
| ATE241600T1 (de) * | 1996-06-29 | 2003-06-15 | Samjin Pharm Co Ltd | Piperazin-derivate und verfahren zu ihrer herstellung |
| KR20010012326A (ko) * | 1997-05-07 | 2001-02-15 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | 치환 3,3-디아미노-2-프로펜니트릴, 그것의 제조방법 및사용 |
| US5955548A (en) * | 1997-05-07 | 1999-09-21 | Novo Nordisk A/S | Substituted 3, 3-diamino-2-propenenitriles, their preparation and use |
| GB0022215D0 (en) * | 2000-09-11 | 2000-10-25 | Boehringer Ingelheim Pharma | Method for the treatment of thromboembolic disorders in patients with aspirin« resistance |
| UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
| US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
| AU2002357137A1 (en) * | 2001-12-10 | 2003-06-23 | Bristol-Myers Squibb Company | (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase |
| US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
| DE10209982A1 (de) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma | Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe |
| PL1912650T3 (pl) | 2005-08-03 | 2018-01-31 | Sprout Pharmaceuticals Inc | Zastosowanie flibanseryny w leczeniu otyłości |
| US20090312242A1 (en) | 2006-06-30 | 2009-12-17 | Ramiro Castro | Flibanserin for the treatment of urinary incontinence and related diseases |
| UY31335A1 (es) | 2007-09-12 | 2009-04-30 | Tratamiento de sintomas vasomotores | |
| EP2234608A2 (en) | 2007-12-11 | 2010-10-06 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
| CA2686480A1 (en) | 2008-12-15 | 2010-06-15 | Boehringer Ingelheim International Gmbh | New salts |
| AU2013292519B2 (en) | 2012-07-19 | 2017-12-07 | Drexel University | Sigma receptor ligands for modulating cellular protein homeostasis |
| US11117870B2 (en) | 2017-11-01 | 2021-09-14 | Drexel University | Compounds, compositions, and methods for treating diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3932403A1 (de) * | 1989-05-12 | 1991-04-11 | Thomae Gmbh Dr K | Neue arylsulfonamide, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| IL94805A (en) * | 1989-06-28 | 1994-04-12 | Ciba Geigy Ag | Certain translocated carboxylic acids (a) Arylsulfonamide - and pyridyl - or imidazolil (), process for their preparation and pharmaceutical preparations containing them |
| DE4037112A1 (de) * | 1990-11-22 | 1992-05-27 | Thomae Gmbh Dr K | Neue pyridylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
-
1992
- 1992-05-18 DE DE4216364A patent/DE4216364A1/de not_active Withdrawn
- 1992-05-21 DE DE4216829A patent/DE4216829A1/de not_active Withdrawn
- 1992-11-05 TW TW081108864A patent/TW293816B/zh not_active IP Right Cessation
- 1992-12-09 PL PL92312869A patent/PL171463B1/pl not_active IP Right Cessation
- 1992-12-09 PL PL92312868A patent/PL171500B1/pl not_active IP Right Cessation
- 1992-12-09 PL PL92296896A patent/PL171512B1/pl not_active IP Right Cessation
- 1992-12-11 JP JP4331452A patent/JP2965425B2/ja not_active Expired - Fee Related
- 1992-12-11 NZ NZ245445A patent/NZ245445A/en unknown
- 1992-12-11 AT AT92121126T patent/ATE122658T1/de active
- 1992-12-11 DE DE59202241T patent/DE59202241D1/de not_active Expired - Lifetime
- 1992-12-11 IL IL10406692A patent/IL104066A/en not_active IP Right Cessation
- 1992-12-11 HU HU9203949A patent/HUT68032A/hu unknown
- 1992-12-11 DK DK92121126.4T patent/DK0547517T3/da active
- 1992-12-11 ES ES92121126T patent/ES2074323T3/es not_active Expired - Lifetime
- 1992-12-11 AU AU30058/92A patent/AU653455B2/en not_active Ceased
- 1992-12-11 CA CA002085201A patent/CA2085201C/en not_active Expired - Fee Related
- 1992-12-11 HU HU9203949A patent/HU9203949D0/hu unknown
- 1992-12-11 NO NO924800A patent/NO179173C/no not_active IP Right Cessation
- 1992-12-11 EP EP92121126A patent/EP0547517B1/de not_active Expired - Lifetime
- 1992-12-12 KR KR1019920024089A patent/KR100227441B1/ko not_active IP Right Cessation
- 1992-12-14 RU RU92004567A patent/RU2119915C1/ru not_active IP Right Cessation
- 1992-12-14 FI FI925665A patent/FI100882B/fi not_active IP Right Cessation
-
1994
- 1994-07-05 US US08/270,615 patent/US5482948A/en not_active Expired - Lifetime
-
1995
- 1995-06-02 HU HU95P/P00160P patent/HU211230A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2085201A1 (en) | 1993-06-15 |
| US5482948A (en) | 1996-01-09 |
| CA2085201C (en) | 2004-07-06 |
| ES2074323T3 (es) | 1995-09-01 |
| IL104066A (en) | 1996-07-23 |
| KR100227441B1 (ko) | 1999-11-01 |
| HU9203949D0 (en) | 1993-03-29 |
| IL104066A0 (en) | 1993-05-13 |
| AU653455B2 (en) | 1994-09-29 |
| RU2119915C1 (ru) | 1998-10-10 |
| ATE122658T1 (de) | 1995-06-15 |
| HUT68032A (en) | 1995-05-29 |
| PL296896A1 (en) | 1993-11-29 |
| DE4216364A1 (de) | 1993-11-25 |
| FI100882B (fi) | 1998-03-13 |
| HU211230A9 (en) | 1995-11-28 |
| PL171500B1 (en) | 1997-05-30 |
| DK0547517T3 (da) | 1995-09-04 |
| DE4216829A1 (de) | 1993-11-25 |
| FI925665A (fi) | 1993-06-15 |
| NO179173B (no) | 1996-05-13 |
| NO179173C (no) | 1996-08-21 |
| EP0547517A1 (de) | 1993-06-23 |
| NO924800D0 (no) | 1992-12-11 |
| EP0547517B1 (de) | 1995-05-17 |
| NZ245445A (en) | 1995-06-27 |
| DE59202241D1 (de) | 1995-06-22 |
| JP2965425B2 (ja) | 1999-10-18 |
| JPH06199793A (ja) | 1994-07-19 |
| FI925665A0 (fi) | 1992-12-14 |
| TW293816B (no) | 1996-12-21 |
| PL171512B1 (pl) | 1997-05-30 |
| AU3005892A (en) | 1993-06-17 |
| PL171463B1 (pl) | 1997-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO924800L (no) | Nye pyridylderivater, legemidler inneholdende dem, og fremgangsmaate for deres fremstilling | |
| DE69501947D1 (de) | SUBSTITUIERTE AROMATISCHE VERBINDUNGEN ALS c. AMP PHOSPHODIESTERASE-UND TNF-HEMMER | |
| ATE82966T1 (de) | Pyridincarboxamid-derivate und ihre verwendung als fungizides mittel. | |
| WO1995032190A3 (en) | Pharmaceutical diketopiperazine compounds | |
| FI955012A0 (fi) | Herbisidiset (4-substituoitu pyridyyli)-3-karbinolit | |
| DK586583A (da) | 2-(heterocyclylaminoalkoxymethyl)-4-(aryl eller heteroaryl)-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere og farmaceutisk acceptable syreadditionssalte deraf, anvendelse af disse forbindelser som laegemidler og farmaceutisk praeparat indeh. saadanne forb. | |
| WO2002034754A3 (en) | Benzoxazinone derivatives, their preparation and use | |
| DE69738907D1 (de) | Neue diamidverbindungen und medikamente die diese enthalten | |
| DK0397044T3 (da) | Hidtil ukendte arylsulfonamider, lægemidler, der indeholder disse forbindelser, og fremgangsmåder til deres fremstilling | |
| DK0419676T3 (da) | Thionaphthalenderivater, fremgangsmåde til fremstilling deraf og anti-allergipræparat indeholdende samme | |
| TR24930A (tr) | Kuslarin kontrol edilmesinde veya bununla ilgili gelismeler | |
| DK0487095T3 (da) | Hidtil ukendte pyridylderivater, lægemidler, der indeholder disse forbindelser, og fremgangsmåder til deres fremstilling | |
| ES2012687A6 (es) | Procedimiento de preparacion de derivados 1,4-dihidro-piridinas. | |
| IL92646A0 (en) | Imidazolyl and pyridyl derivatives of phenyl substituted 1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them | |
| FR2674246B1 (fr) | Nouveaux derives de l'acide alpha-methylene 5-thiazolacetique, leur procede de preparation et les intermediaires de ce procede, leur application a titre de fongicides et les compositions les renfermant. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |